Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer
NCT07265739Phase 2Not yet recruiting
- Sponsor
- Massachusetts General Hospital
- Start
- Feb 2027
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of losartan, sponsored by Massachusetts General Hospital. Planned start Feb 2027; status: not yet recruiting.
02
Drugs
losartan
Beyond the preview
Go deeper on NCT07265739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07265739.